Overview

Gene Expression Analysis Market Introduction:

Gene expression analysis market is forecasted to value over USD 7.6 billion by 2027 end and register a CAGR of over 8.4% by 2027 end.

The increasing prevalence, decreasing cost of sequencing and the rising application areas of genomics are fueling the growth of market. In addition, the increasing focus on advanced healthcare system alongside growing preference towards advanced technology in drug development and modern diagnostics is driving the market. Implementation of an initiative like the Precision Medicine Initiative (PMI) has boosted the market growth.

The gene expression analysis market is bifurcated into by process, by product, by capacity, by technique, by application, and by region. In terms of process, PCR analysis is expected to hold a major share of the market owing to the frequent upgradations deployed in qPCR and high adoption of these systems. Moreover, the integration of these systems with other steps is positively influencing the market. PCR analysis is prominently preferred by biologists to study the expressions of multiple microorganisms.

Based on product, kits & reagents are expected to dominate the market owing to its low price and enhanced efficiency. Due to its low price, there has been a high usage of these products. The introduction of novel kits and reagents has increased sales thus propelling the market. Furthermore, increasing demand for better visualization and data interpretation is resulting in prominent players enhancing bioinformatics tools, thus expanding the gene expression analysis market size.

In terms of capacity, low to mid plex is expected to show notable growth. Advancements in stem cell research and an increase in the number of research projects related to single-cell analysis are the major factors expanding the market. Additionally, the development of multiplexed digital characterization systems is positively influencing the market.

Based on the technique, RNA expression is the front runner of the market. The rising demand for DNA microarrays and PCR analysis has resulted in the inflation of the market. Besides, the integration of immunoprecipitation assay with these techniques has also positively influenced the market. The emergence of upcoming next-generation sequencing is expected to propagate the market growth further.

In terms of application, drug development is expected to control the growth of the market. Factors such as high cost and time have gathered the interest of prominent pharmaceutical players to invest in it. The commercial launch aspect has played a catalyst role in the growth of the market.

North America is forecasted dictate market growth. Development of gene therapy, availability of NGS funding and government initiatives are the key factors bolstering the market in the region. Asia-Pacific region represents a lucrative opportunity for manufacturers owing to increasing domestic manufacturing for sequencing systems and increasing bioresearch centres. Furthermore, a rise in the research & development activities and improving healthcare infrastructure is accelerating the growth of the market in the region.

Major players of the market are:
Thermo Fisher Scientific, Illumina, Inc., Agilent Technologies, QIAGEN N.V, PerkinElmer, BGI, GE Healthcare, Hoffman-La Roche Ltd, Bio-Rad Laboratories, Inc. and Pacific Biosciences of California, Inc.

Market Segmentation:

By Process

Sample Collection
Purification
cDNA synthesis & conversion
PCR Analysis
Data analysis & interpretation

By Product

Kits & Reagents
DNA Chips
Others

By Capacity

Low- to Mid- Plex
High-Plex

By Technique

RNA Expression
Northern Blotting
DNA Microarrays
PCR Techniques
RNA-Seq
Promoter Analysis
In vitro Transcription/Nuclear Run-On Assays
Gel Shift Assays
Chromatin Immunoprecipitation (ChIP)
Protein Expression & Posttranslational Modification Analysis
Western Blotting
2-D Gel Electrophoresis
Immunoassays
Mass Spectrometry

By Application

Drug Discovery & Development
Clinical Diagnostics
Biotechnology & Microbiology
Others

By Region:

North America
Europe
Asia Pacific
Latin America
Rest of the World

Competitive Landscape:

Biorad acquired RainDance Technologies in 2017. RainDance Technologies is a droplet-based PCR systems manufacturers and has an accurate portfolio
Thermo Fisher Scientific acquired Affymetrix. The move bolstered Thermo Fisher Scientific's foothold in genetic analysis and cellular products

FutureWise Key Takeaways:

Growth Prospects
SWOT Analysis
Key Trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the gene expression analysis market by process, by product, by capacity, by technique, by application, and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
Evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and the rest of the world
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financial and core competencies

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com